Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 7, 2010, Pages 3141-3145

  Ploss, Alexander ^a   Khetani, Salman R ^b,e   Jones, Christopher T ^a   Syder, Andrew J ^a,f   Trehan, Kartik ^b   Gaysinskaya, Valeriya A ^a   Mu, Kathy ^a   Ritola, Kimberly ^a   Rice, Charles M ^a   Bhatia, Sangeeta N ^b,c,d  

^a ROCKEFELLER UNIVERSITY   (United States)

^b USA   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Hepregen Corporation   (United States)

^f iTherx Pharmaceuticals   (United States)

Author keywords

Drug development; Infection; Liver; Tissue engineering; Viral hepatitis

Indexed keywords

BETA NAPHTHOFLAVONE; CD18 ANTIGEN; CLAUDIN 1; MULTIDRUG RESISTANCE PROTEIN 2; PHENOBARBITAL; PROTEIN ZO1; RIFAMPICIN; SCAVENGER RECEPTOR BI;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CULTURE; PRIORITY JOURNAL; TISSUE ENGINEERING; VIRUS CULTURE; VIRUS REPLICATION;

ANTIBODIES, MONOCLONAL; CELL CULTURE TECHNIQUES; CELLS, CULTURED; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; TISSUE ENGINEERING; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 77649262300     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0915130107     Document Type: Article

References (32)

1. Durantel D, Zoulim F (2007) Going towards more relevant cell culture models to study the in vitro replication of serum-derived hepatitis C virus and virus/host cell interactions? J Hepatol 46:1-5.
2. Hsu IC, et al. (1993) p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 14:987-992.
3. Nagao K, et al. (2005) Expression of hTERT mRNA in a mortal liver cell line during S phase without detectable telomerase activity. Int J Mol Med 15:683-688.
4. Yokoo H, et al. (2004) Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells. Hepatology 40:609-617.
5. Fournier C, et al. (1998) In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J Gen Virol 79:2367-2374.
6. Bhatia SN, Balis UJ, Yarmush ML, Toner M (1999) Effect of cell-cell interactions in preservation of cellular phenotype: Cocultivation of hepatocytes and nonparenchymal cells. FASEB J 13:1883-1900.
7. Carloni G, et al. (1993) Susceptibility of human liver cell cultures to hepatitis C virus infection. Arch Virol Suppl 8:31-39.
8. Iacovacci S, et al. (1993) Replication and multiplication of hepatitis C virus genome in human foetal liver cells. Res Virol 144:275-279.
9. Rumin S, et al. (1999) Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. J Gen Virol 80:3007-3018.
10. Buck M (2008) Direct infection and replication of naturally occurring hepatitis C virus genotypes 1, 2, 3 and 4 in normal human hepatocyte cultures. PLoS One 3:e2660.
11. Lázaro CA, et al. (2007) Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol 170:478-489.
12. Khetani SR, Bhatia SN (2008) Microscale culture of human liver cells for drug development. Nat Biotechnol 26:120-126.
13. SivaramanA, et al. (2005)Amicroscale in vitro physiologicalmodel of the liver: Predictive screens for drug metabolism and enzyme induction. Curr Drug Metab 6:569-591.
14. LeCluyse EL (2001) Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci 13:343-368.
15. Evans MJ, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-805.
16. Liu S, et al. (2009) Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 83:2011-2014.
17. Ploss A, et al. (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457:882-886.
18. Pileri P, et al. (1998) Binding of hepatitis C virus to CD81. Science 282:938-941.
19. Scarselli E, et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21:5017-5025.
20. Marukian S, et al. (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48:1843-1850.
21. Stiffler JD, et al. (2009) Focal distribution of hepatitis C virus RNA in infected livers. PLoS One 4:e6661.
22. Jones CT, et al. (2010) Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol, in press.
23. Lindenbach BD, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309:623-626.
24. Catanese MT, et al. (2007) High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol 81:8063-8071.
25. Meuleman P, et al. (2008) Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo. Hepatology 48:1761-1768.
26. Owsianka A, et al. (2005) Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J Virol 79:11095-11104.
27. Hadlock KG, et al. (2000) Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J Virol 74:10407-10416.
28. Law M, et al. (2008) Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med 14:25-27.
29. Gale M, Jr, Foy EM (2005) Evasion of intracellular host defence by hepatitis C virus. Nature 436:939-945.
30. Liang Y, et al. (2009) Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 137:1448-1458.
31. Flint M, et al. (1999) Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 73:6235-6244.
32. Madan A, et al. (2003) Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos 31: 421-431.